| Availability: | |
|---|---|
| PDF Export | |
M3
Medlere
HLC1001
Ion-exchange HPLC technology ensures high analytical accuracy and consistency, supporting confident clinical decision-making in diabetes management.
Meets NGSP and IFCC traceability standards for HbA1c testing, ensuring alignment with internationally recognized reference systems.
Demonstrates excellent correlation with reference HPLC methods (r² ≥ 0.99), supporting result reliability and clinical confidence.
Designed to minimize the impact of common hemoglobin variants, improving result reliability in diverse patient populations.
Rapid turnaround time and automated workflow help streamline laboratory operations and increase daily testing capacity.
Supports β-Thalassemia screening alongside HbA1c measurement, providing additional clinical value in routine testing.
Direct sampling without removing tube caps enhances biosafety while simplifying workflow for laboratory staff.
Why Choose Ion-Exchange HPLC for HbA1c Testing?
Unlike immunoassay-based methods, HPLC separates hemoglobin fractions, reducing the risk of analytical interference.
HPLC enables identification of hemoglobin variants, supporting more accurate interpretation of HbA1c results.
Recognized as a reference method in many laboratories, HPLC provides high reproducibility and traceability.
By combining precision, specificity, and variant awareness, HPLC supports more reliable diabetes diagnosis and monitoring.
Suitable for medium to high-throughput laboratories requiring accurate and standardized HbA1c testing.
Supports long-term glycemic monitoring with reliable and reproducible results for patient follow-up.
Ideal for routine health check-ups and early detection programs, enabling efficient large-scale screening.